/PRNewswire/ NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced financial results for the year ended.
/PRNewswire/ NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced the appointment of D. Gordon Strickland.
/PRNewswire/ NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced the appointment of D. Gordon Strickland.
BOSTON, Jan. 28, 2022 /PRNewswire/ NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company, today announced the appointment of D. Gordon Strickland to its Board of Directors,. | January 28, 2022